TABLE 3.
Factors predicting in-stent restenosis.
| Items | Univariate logistic regression model |
|||
| P-value | OR | 95% CI |
||
| Lower | Higher | |||
| Age | 0.111 | 1.043 | 0.990 | 1.098 |
| Male | 0.326 | 2.121 | 0.473 | 9.504 |
| BMI | 0.486 | 1.043 | 0.927 | 1.174 |
| Current smoke | 0.364 | 1.566 | 0.595 | 4.126 |
| Hypertension | 0.126 | 2.678 | 0.759 | 9.445 |
| Diabetes mellitus | 0.021 | 2.981 | 1.177 | 7.550 |
| Hypercholesteremia | 0.024 | 4.238 | 1.206 | 14.894 |
| Hyperuricemia | 0.055 | 2.479 | 0.982 | 6.255 |
| Family history of CAD | 0.297 | 1.714 | 0.622 | 4.721 |
| MAP | 0.778 | 1.004 | 0.979 | 1.029 |
| FBG | 0.037 | 1.489 | 1.024 | 2.164 |
| Glycated hemoglobin | 0.927 | 1.012 | 0.788 | 1.299 |
| Scr | 0.109 | 1.023 | 0.995 | 1.052 |
| SUA | 0.014 | 1.008 | 1.002 | 1.014 |
| TG | 0.634 | 1.129 | 0.685 | 1.862 |
| TC | 0.919 | 1.024 | 0.644 | 1.631 |
| LDL-C | 0.133 | 1.787 | 0.839 | 3.808 |
| HDL-C | 0.027 | 0.092 | 0.011 | 0.758 |
| HsCRP | 0.004 | 1.152 | 1.047 | 1.268 |
| ESR | 0.262 | 1.027 | 0.980 | 1.076 |
| WBC | 0.347 | 1.157 | 0.854 | 1.566 |
| Neutrophil | 0.256 | 1.324 | 0.816 | 2.148 |
| LVEF | 0.158 | 0.950 | 0.884 | 1.020 |
| cTnI | 0.261 | 1.012 | 0.991 | 1.033 |
| NT-proBNP | 0.404 | 1.003 | 0.996 | 1.010 |
| Multivessel artery lesions | 0.078 | 3.815 | 0.860 | 16.923 |
| Target lesion at LAD | 0.526 | 1.363 | 0.523 | 3.552 |
| Target lesion at LCX | 0.031 | 2.800 | 1.096 | 7.150 |
| Target lesion at RCA | 0.691 | 0.824 | 0.316 | 2.148 |
| Patients with two target lesions | 0.016 | 3.174 | 1.241 | 8.119 |
| Stenosis degree of target lesion | 0.199 | 1.068 | 0.966 | 1.181 |
| Length of target lesion | 0.020 | 1.064 | 1.010 | 1.122 |
| Length of stent | 0.023 | 1.062 | 1.009 | 1.118 |
| Diameter of stent | 0.686 | 0.755 | 0.194 | 2.944 |
| Time of stent dilation | 0.753 | 0.981 | 0.873 | 1.103 |
| Balloon dilation pre stent | 0.914 | 0.947 | 0.349 | 2.571 |
| β receptor blockers | 0.352 | 0.574 | 0.179 | 1.846 |
| ACEIs/ARBs | 0.198 | 0.547 | 0.218 | 1.372 |
| Calcium channel blockers | 0.881 | 0.926 | 0.341 | 2.515 |
Factors predicting in-stent restenosis were analyzed by univariate logistic regression model. Boldface represented P value < 0.05. OR, odds ratio; CI, confidence interval; BMI, body mass index; CAD, coronary artery disease; MAP, mean arterial pressure; FBG, fasting blood-glucose; Scr, serum creatinine; SUA, serum uric acid; TG, triglyceride; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; HsCRP, high-sensitivity C-reactive protein; ESR, erythrocyte sedimentation rate; WBC, white blood cell; LVEF, left ventricular ejection fraction; cTnI, cardiac troponin I; NT-proBNP, N-terminal-proB-type natriuretic peptide; LAD, left anterior descending branch; LCX, left circumflex artery; RCA, right coronary artery; ACEIs, angiotensin converting enzymes inhibitors; ARBs, angiotensin receptor blockers.